Organization | Nuvisan Pharma Services

Nuvisan Pharma Services Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4

Founded: ULm Germany (1979)

Organization Overview

First Clinical Trial

2003

NCT00189969

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Active Ingredients

Drugs in Phase 4 Trials (3)

Key: Nuvisan Pharma Services (1) Acquired (2)

ezetimibe (zetia) (1 trial)

pancrelipase (creon) (1 trial)

simvastatin (zocor) (1 trial)

Drugs in Phase 3 Trials (4)

Key: Nuvisan Pharma Services (0) Acquired (4)

capecitabine (xeloda) (1 trial)

desloratadine (clarinex) (1 trial)

doxorubicin (Doxil) (3 trials)

infliximab (remicade) (1 trial)

Drugs in Phase 2 Trials (5)

Key: Nuvisan Pharma Services (3) Acquired (2)

as03 (1 trial)

carboplatin (paraplatin) (1 trial)

kleb4v (1 trial)

slx4090 (1 trial)

temozolomide (temodar) (1 trial)

Drugs in Phase 1 Trials (22)

aon-d21 (2 trials)

atorvastatin (lipitor) (1 trial)

bacille calmette-guerin (1 trial)

carbidopa (sinemet) (1 trial)

contraloid (1 trial)

elstree-bn (1 trial)

Filgrastim (neupogen) (2 trials)

glycopyrronium (robinul) (1 trial)

ifx-1 (1 trial)

levodopa (larodopa) (1 trial)

midazolam (versed) (1 trial)

mt-3995 (1 trial)

odm-104 (1 trial)

orismilast (1 trial)

Pegfilgrastim (1 trial)

prs-080 (1 trial)

prucalopride (1 trial)

pur 0110 (1 trial)

rifabutin (mycobutin) (2 trials)

sodium chloride (1 trial)

spc4955 (1 trial)

warfarin (coumadin) (1 trial)

Drugs in Other Trials (1)

Key: Nuvisan Pharma Services (0) Acquired (1)

oxytocin (syntocinon) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Alzheimer Disease (Phase 1)

Colitis (Phase 1)

Colitis, Ulcerative (Phase 1)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Exocrine Pancreatic Insufficiency (Phase 4)

Hypercholesterolemia (Phase 1)

Hyperhidrosis (Phase 1)

Hypertriglyceridemia (Phase 2)

Smallpox (Phase 1)

Tuberculosis (Phase 1)

Ulcer (Phase 1)

Vaccinia (Phase 1)

Overview

Highest Phase: Phase 4
# of Trials: 30
# of Trial APIs: 35